This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Aug 15;369(7):670-1.

doi: 10.1056/NEJMe1307059.

A role for finasteride in the prevention of prostate cancer?

Michael LeFevre

PMID: 23944306
DOI: 10.1056/NEJMe1307059

Editorial

A role for finasteride in the prevention of prostate cancer?

Michael LeFevre. N Engl J Med. 2013.

. 2013 Aug 15;369(7):670-1.

doi: 10.1056/NEJMe1307059.

Author

Michael LeFevre

PMID: 23944306
DOI: 10.1056/NEJMe1307059

No abstract available

PubMed Disclaimer

Comment on

Long-term survival of participants in the prostate cancer prevention trial.
Thompson IM Jr, Goodman PJ, Tangen CM, Parnes HL, Minasian LM, Godley PA, Lucia MS, Ford LG. Thompson IM Jr, et al. N Engl J Med. 2013 Aug 15;369(7):603-10. doi: 10.1056/NEJMoa1215932. N Engl J Med. 2013. PMID: 23944298 Free PMC article.

Similar articles

Prostate cancer prevention with 5 alpha-reductase inhibitors.
Parekh DJ. Parekh DJ. Recent Results Cancer Res. 2011;188:109-14. doi: 10.1007/978-3-642-10858-7_9. Recent Results Cancer Res. 2011. PMID: 21253793 Review. No abstract available.
Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.
Barton MK. Barton MK. CA Cancer J Clin. 2011 Jan-Feb;61(1):1-2. doi: 10.3322/caac.20100. Epub 2011 Jan 3. CA Cancer J Clin. 2011. PMID: 21199914 No abstract available.
Survival in the prostate cancer prevention trial.
Revannasiddaiah S, Susheela SP. Revannasiddaiah S, et al. N Engl J Med. 2013 Nov 14;369(20):1967. doi: 10.1056/NEJMc1311498. N Engl J Med. 2013. PMID: 24224634 No abstract available.
Survival in the prostate cancer prevention trial.
Walsh PC. Walsh PC. N Engl J Med. 2013 Nov 14;369(20):1967. doi: 10.1056/NEJMc1311498. N Engl J Med. 2013. PMID: 24224633 No abstract available.
Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.
Reddy GK. Reddy GK. Clin Prostate Cancer. 2004 Mar;2(4):206-8. doi: 10.1016/s1540-0352(11)70045-2. Clin Prostate Cancer. 2004. PMID: 15072601 Review. No abstract available.

See all similar articles

Cited by

How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss.
Trüeb RM, Luu NC, Gavazzoni Dias MFR, Dutra Rezende H. Trüeb RM, et al. Skin Appendage Disord. 2022 May;8(3):245-248. doi: 10.1159/000520493. Epub 2022 Jan 10. Skin Appendage Disord. 2022. PMID: 35707289 Free PMC article.
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality.
Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D'Agostino R Jr, Loo RK, Aaronson DS, Horwitz RI, Jacobsen SJ. Wallner LP, et al. Urology. 2018 Sep;119:70-78. doi: 10.1016/j.urology.2018.05.033. Epub 2018 Jun 12. Urology. 2018. PMID: 29906480 Free PMC article.
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia.
Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D'Agostino R Jr, Loo RK, Aaronson DS, Richert-Boe K, Horwitz RI, Jacobsen SJ. Wallner LP, et al. Mayo Clin Proc. 2016 Dec;91(12):1717-1726. doi: 10.1016/j.mayocp.2016.07.023. Epub 2016 Oct 27. Mayo Clin Proc. 2016. PMID: 28126151 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information